GenX Laboratories

GenX Laboratories is a pharmaceutical manufacturing company based in Hyderabad, India, that specializes in the development and production of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. In 2015, the company was acquired by Aurobindo Pharma to strengthen the parent organization's API manufacturing capacity and backward integration strategy. GenX Laboratories focuses on several key therapeutic areas, including cardiovascular health, central nervous system disorders, and metabolic diseases such as diabetes. The company operates state-of-the-art manufacturing facilities that comply with international regulatory standards, including USFDA and EU-GMP. In addition to its own product portfolio, GenX Laboratories provides Contract Research and Manufacturing Services (CRAMS) to global pharmaceutical partners. The company is recognized for its expertise in complex chemical synthesis and large-scale commercial production.